ASPI ASP Isotopes Inc. Common Stock
Basic MaterialsAs of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
2.32
P/S
17.13
EV/EBITDA
-3.02
DCF Value
$-3.96
FCF Yield
-14.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
17.6%
Operating Margin
-275.3%
Net Margin
-644.4%
ROE
-117.2%
ROA
-29.5%
ROIC
-13.0%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $4.2M | $-6.9M | $— |
| Q4 null | $16.7M | $-78.7M | $— |
| FY null | $23.8M | $-175.1M | $— |
| Q3 null | $4.9M | $-12.9M | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$13.00
Target (Median)
$13.00
Target Range
$13.00 - $13.00
Trading Activity
Insider Trades
View AllLatest News
Company Info
Sector
Basic Materials
Industry
Chemicals
Country
US
Exchange
—
Beta
3.27
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.